Aspirin; propoxyphene hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for aspirin; propoxyphene hydrochloride and what is the scope of freedom to operate?
Aspirin; propoxyphene hydrochloride
is the generic ingredient in one branded drug marketed by Xanodyne Pharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for aspirin; propoxyphene hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | aspirin; propoxyphene hydrochloride at DailyMed |
Recent Clinical Trials for aspirin; propoxyphene hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
US Patents and Regulatory Information for aspirin; propoxyphene hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xanodyne Pharm | DARVON W/ ASA | aspirin; propoxyphene hydrochloride | CAPSULE;ORAL | 010996-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |